Clinical trial for Influenza Vaccination
Official title Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults
ClinicalTrials.gov ID: NCT07838298
What this study is testing
What is Standard dose influenza vaccine?
Standard dose influenza vaccine is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for influenza vaccination.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to compare immune responses to different influenza vaccine formulations in older adults and to understand how immune aging and repeated annual influenza vaccination affect these responses. The main questions it aims to answer are: Do standard dose, MF59 adjuvanted, and high dose influenza vaccines produce different immune responses in adults aged 65 years or older?
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older. Healthy volunteers may be eligible.
You may be able to join if
- Older adult group: aged 65 years or older
- Younger reference group: aged 19 to 49 years
- Able to receive influenza vaccination and complete the scheduled follow up
You likely can't join if
- Receipt of an influenza vaccine or any other vaccine within 4 weeks prior to enrollment
- Immunocompromised status, including ongoing chemotherapy or immunosuppressive therapy, high dose corticosteroid therapy, history of solid organ or...
- Moderate or severe acute infection
- History of allergic reaction to an influenza vaccine or any of its components, or any other condition that precludes influenza vaccination
- Inability, as determined by the investigator, to understand the purpose and procedures of the study and provide voluntary informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.